Federal lawmakers requested action this week on restoring medical marijuana access to veterans, while proponents in Arizona came one step closer to qualifying to the November ballot. Click here to get the latest news and to find out how you can #TakeAction.
Federal lawmakers pressured President Obama this week to take executive action to reform marijuana policy. Meanwhile, state legislative reforms are still moving forward throughout the country. Click here to get the latest news and to learn what you can do to take action.
A recent memorandum from the US Drug Enforcement Administration to several United States Senators indicates that the agency is prepared to respond in the coming months to a five-year-old petition seeking to amend the plant’s status as a schedule I prohibited substance. Under the US Controlled Substances Act of 1970, the cannabis plant and its organic cannabinoids are classified as schedule I prohibited substances — the most restrictive category available under the law. As summarized by the DEA, “Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence.” Explicitly, substances in this category must meet three specific inclusion criteria: The substance must possess “a high potential for abuse”; it must…
US Senators Kirsten Gillibrand (D-NY) and Corey Booker (D-NJ) give ATTN an interview on medical cannabis, calls for federal reforms and the need for the Drug Enforcement Administration (DEA) ‘to do their homework…meet with the parents of children who need access to medical marijuana’.
While many are already celebrating the holidays with family and loved ones, we didn’t want to miss the chance to spotlight some important marijuana law reforms that have taken place this past week. We have exciting news internationally, federally, and in several states! Keep reading below to find out more!
This week was a busy one for marijuana law reform around the country. There were several election day measures and a new bill was introduced in the Senate. Click here to take a closer look at this week’s marijuana happenings
Members of the US Senate at a hearing yesterday expressed skepticism in regard to federal policies limiting the ability of investigators to engage in clinical studies of marijuana’s health benefits. Senators heard from representatives from the Drug Enforcement Administration (DEA), Food and Drug Administration (FDA), National Institute on Drug Abuse (NIDA), University of Mississippi Medical Center, Arrowhead Regional Medical Center and Project SAM on a variety of issues The hearing’s most noteworthy moment came when Nora Volkow, director of NIDA, acknowledged that the monopoly on marijuana cultivation for research purposes […]
Help save one of America’s original medical marijuana collectives for patients in Santa Cruz, California.
Yavapai County Prosecutor Using Government Money To Oppose Marijuana Legalization
Drug Enforcement Administration head Michele Leonhart is stepping down, US Attorney General Eric Holder has confirmed. She is expected to leave the agency in mid-May.